Stay updated on Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial

Sign up to get notified when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a minor update to the page's versioning rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-29T19:30:07.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5. This reflects a minor maintenance update to the page metadata.
    Difference
    0.1%
    Check dated 2026-08-08T19:28:52.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page shows a new revision version in the footer, updating from v3.6.3 to v3.6.4 to reflect a small update to the study page.
    Difference
    0.1%
    Check dated 2026-07-25T11:45:25.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.3, replacing the previous v3.6.2 and indicating a new site release.
    Difference
    0.1%
    Check dated 2026-07-03T23:43:07.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This reflects a behind-the-scenes update to the page's underlying template or metadata rather than a user-facing content change.
    Difference
    0.1%
    Check dated 2026-06-26T23:58:27.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Recruitment status on the study page now shows 'No longer looking for participants', indicating the study is no longer enrolling. The changes also add new help and navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and update the Intervention/Treatment label and revision footer to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:45:41.000Z thumbnail image

Stay in the know with updates to Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.